ROYAL BANK OF CANADA - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 45 filers reported holding PROTEON THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$10,000
+42.9%
4,398
+14.3%
0.00%
Q3 2018$7,000
-22.2%
3,848
+0.6%
0.00%
Q2 2018$9,000
-10.0%
3,8250.0%0.00%
Q1 2018$10,000
+42.9%
3,8250.0%0.00%
Q4 2017$7,0000.0%3,825
+13.3%
0.00%
Q3 2017$7,000
-22.2%
3,375
-43.2%
0.00%
Q2 2017$9,000
-40.0%
5,940
-32.6%
0.00%
Q1 2017$15,000
-34.8%
8,815
-27.1%
0.00%
Q4 2016$23,000
+283.3%
12,090
+1760.0%
0.00%
Q3 2016$6,000
-45.5%
650
-16.2%
0.00%
Q3 2015$11,000
+37.5%
776
+63.4%
0.00%
Q2 2015$8,0004750.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders